Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07198139 · ClinicalTrials.gov registry record · Phase 1
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Snow Mountain Virus
A Phase 1 study of Norovirus, sponsored by Cocrystal Pharma.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT07198139 is a Phase 1 study of Norovirus that is actively recruiting participants, run by Cocrystal Pharma. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07198139, a Phase 1 study of Norovirus, is actively recruiting participants, sponsored by Cocrystal Pharma.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Participants in this study will be given either CDI-988 or placebo orally before receiving a norovirus challenge virus and continuing for 5 days. Participants will not know whether they are getting placebo or CDI-988. The study will evaluate how well CDI-988 compared to placebo can reduce the incidence of clinical symptoms after a challenge with norovirus. The amount of virus in stool samples will be measured over time. Side effects and pharmacokinetics (the amount of CDI-988 in blood) will also be measured.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG CDI-988
- OTHER Snow Mountain Virus
Study Locations (1)
Georgia
- Hope Clinic of the Emory Vaccine Center - Decatur
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-03-01 |
| Est. Completion | 2026-12-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07198139
The ClinicalTrials.gov registry entry for NCT07198139 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cocrystal Pharma, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Norovirus appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT07198139 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT07198139 about?
NCT07198139 is a clinical study titled "A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Snow Mountain Virus". Participants in this study will be given either CDI-988 or placebo orally before receiving a norovirus challenge virus and continuing for 5 days. Participants will not know whether they are getting placebo or CDI-988. The study will evaluate how well CDI-988 compared to placebo can reduce the incide...
What is the current status of trial NCT07198139?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2026-03-01. Estimated completion is 2026-12-01.
What conditions does trial NCT07198139 study?
This clinical trial studies the following conditions: Norovirus.
What interventions are being tested in trial NCT07198139?
The interventions under investigation include: Placebo (DRUG), CDI-988 (DRUG), Snow Mountain Virus (OTHER).
Who is sponsoring clinical trial NCT07198139?
This trial is sponsored by Cocrystal Pharma, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07198139 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Norovirus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.